The European Medicines Agency (EMA) has granted Priority Medicine (PRIME) designation to radiprodil, an investigational, potent negative allosteric modulator selectively targeting the ...

The presentations will highlight the company’s ongoing research and development of RAP-219, a clinical-stage AMPA receptor ...

In a recent study, a light-activated allosteric modulator of A 2A R was developed and successfully used to remotely induce sleep by selective light irradiation of the nucleus accumbens in mice.

Presented a poster highlighting the use of the Company’s Magellan™ drug discovery platform to identify allosteric inhibitors targeting discoidin domain receptor 2 at the 36 th EORTC-NCI-AACR Symposium ...

According to the company, this small molecule allosteric modulator of phosphoinositide-3-kinase δ (PI3Kδ) has shown promise ...

The Company granted options to purchase 611,000 shares of Terns common stock to the new employees. The options have a 10-year term and an exercise price per share equal to $2.56, which was the closing ...

Compelling preclinical data in models of both GBA1-PD and idiopathic PD, demonstrating a disease-modifying effect after ...

Tempero Bio has raised $70m in Series B financing to advance its lead candidate TMP-301 through two clinical trials for ...